Table 4.
Study withdrawal reason | n | % |
Discontinuation of tofacitinib due to lack of efficacy | 31 | 77.5% |
Surgery (colectomy) | 5 | 12.5% |
Lack of patient's cooperation with survey completion | 2 | 5.0% |
Discontinuation of tofacitinib due to intolerance or adverse event | 1 | 2.5% |
Othera | 1 | 2.5% |
Patient became pregnant and stopped the medication.